Cypris Therapeutics

Recent Finacing

Pre-Seed

Recent Raise

$0.5M

Cypris Therapeutics applies proprietary synthetic-chemistry technology to design and modify complex, natural-product-inspired small molecules for therapeutically resistant diseases, focusing programs on brain and pancreatic cancers from Ichor's Syracuse incubator.